The validation of predictive biomarkers involves rigorous testing in clinical trials to ensure their reliability and clinical utility. This process includes assessing the sensitivity, specificity, and reproducibility of the biomarkers. Regulatory agencies such as the FDA provide guidelines for the validation and approval of predictive biomarkers to ensure their safe and effective use in clinical settings.
